Related Experiment Video

Updated: Jul 15, 2026

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

17.1K

Relationship Between Changes in the Expression Levels of miR-134 and E2F6 in Mediating Control of Apoptosis in

Yunli Niu1, Houshuo Li1, Wenting Han1

  • 1Department of Ophthalmology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research
|August 20, 2024
PubMed
Abstract

Insights

In NMDA-induced glaucoma, high miR-134 and low E2F6 levels promote retinal ganglion cell apoptosis. Suppressing miR-134 or overexpressing E2F6 inhibits apoptosis, revealing a therapeutic target.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Molecular Biology

Background:

  • Glaucoma is a leading cause of irreversible blindness.
  • N-methyl-D-aspartate (NMDA) induced glaucoma models are crucial for studying disease mechanisms.
  • Apoptosis of retinal ganglion cells (RGCs) is a hallmark of glaucoma progression.

Purpose of the Study:

  • To investigate the relationship between miR-134 and E2F6 in NMDA-induced glaucoma.
  • To determine the role of miR-134 and E2F6 in regulating RGC apoptosis.
  • To explore potential therapeutic targets for glaucoma.

Main Methods:

  • Quantitative analysis of morphological and structural changes in glaucomatous mouse retinas.
  • Assessment of RGC apoptosis and cell viability after transfection.
  • Analysis of the targeting relationship and expression patterns of miR-134 and E2F6.

Main Results:

  • NMDA injection significantly reduced RGC number and internal plexiform layer (IPL) thickness.
  • miR-134 was highly expressed, while E2F6 was lowly expressed in glaucoma mice.
  • Suppression of miR-134 or E2F6 overexpression inhibited RGC apoptosis and promoted proliferation.

Conclusions:

  • miR-134 directly targets and inhibits E2F6 expression.
  • Modulating miR-134 and E2F6 levels offers a potential strategy to reduce glaucomatous RGC apoptosis.
  • Understanding this molecular interplay is key for developing novel glaucoma treatments.
Keywords:
E2F6N-methyl-D-aspartateglaucomamiR-134retinal ganglion cells

More Related Videos

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice09:26

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

19.4K
Combining Optogenetics with Artificial microRNAs to Characterize the Effects of Gene Knockdown on Presynaptic Function within Intact Neuronal Circuits09:17

Combining Optogenetics with Artificial microRNAs to Characterize the Effects of Gene Knockdown on Presynaptic Function within Intact Neuronal Circuits

Published on: March 14, 2018

10.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...